Arvinas

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$11.76
Previous Close
$11.77
Day Range
$11.63-$12.22
52W Range
$5.90-$27
Market Cap
$864.1M
Shares Short
7M

Financials

See more
Revenue (12 Mos)
$312.3M
Revenue Growth (YoY)
-59.1%
Gross Profit (12 Mos)
$312.3M
Diluted EPS
-$0.81

News

See more

Yahoo Finance • 2 days ago

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

Yahoo Finance • 21 days ago

Arvinas outlines plan for $100M share buyback and targets sub-$75M quarterly run rate amid pipeline expansion

Yahoo Finance • 21 days ago

Arvinas GAAP EPS of -$0.48, revenue of $41.9M

Yahoo Finance • last month

Arvinas Presents Preclinical Data for ARV-806 Demonstrating Robust and Differentiated Activity in Models of KRAS G12D-mutated Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

About

CEO
Dr. John G. Houston Ph.D.
CFO
Mr. Andrew R. Saik
Address
5 Science Park, New Haven, CT, United States, 06511
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
430